|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.19 CAD | -13.64% |
|
-9.52% | -9.52% |
| Apr. 08 | Helix BioPharma Corp. announced that it has received CAD 1.915 million in funding | CI |
| Mar. 28 | Helix BioPharma Corp. announced that it expects to receive CAD 1.915 million in funding | CI |
Helix BioPharma Corp. announced the appointment of Mr. Janusz Grabski to the board of directors of the Company with an immediate effect. Mr. Grabski is a lawyer specialized in corporate law and real estate law with over twenty years of experience.
Mr. Grabski is based in Warsaw, Poland. Alongside the appointment, the Company also announces resignation of Mr. Christopher Maciejewski from the board of directors of the Company due to personal reasons.
| 1st Jan change | Capi. | |
|---|---|---|
| -9.52% | 36.68M | |
| +24.79% | 42.68B | |
| -3.27% | 42.4B | |
| +45.32% | 40.04B | |
| -6.20% | 28.31B | |
| +7.58% | 24.94B | |
| -20.02% | 18.96B | |
| +29.25% | 12.3B | |
| -2.77% | 11.95B | |
| -1.48% | 11.55B |
HELIX BIOPHARMA CORP. 
